Suppr超能文献

轻度至中度痴呆患者9个月内决策能力的神经心理学预测指标

Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia.

作者信息

Moye Jennifer, Karel Michele J, Gurrera Ronald J, Azar Armin R

机构信息

Department of Psychiatry, Harvard Medical School and Mental Health Service Line, VA Boston Healthcare System, Boston, MA 02301, USA.

出版信息

J Gen Intern Med. 2006 Jan;21(1):78-83. doi: 10.1111/j.1525-1497.2005.00288.x.

Abstract

BACKGROUND

Older adults with dementia may have diminished capacity to make medical treatment decisions.

OBJECTIVE

To examine rates and neuropsychological predictors of treatment decision making, or consent capacity, among older adults with dementia over 9 months.

DESIGN

Consent capacity was assessed initially and 9 months later in subjects with and without dementia using a longitudinal repeated measures design.

PARTICIPANTS

Fifty-three older adults with dementia and 53 similarly aged adults without dementia.

MEASUREMENTS

A standardized measure MacArthur Competence Assessment Tool-Treatment of 4 legal standards for capacity (Understanding, Appreciation, Reasoning, and Expressing a Choice) and a neuropsychological battery.

RESULTS

In the dementia group, 9.4% had impaired capacity initially, and 26.4% had impaired capacity at 9 months. Mean scores in the dementia group were impaired relative to controls initially and at 9 months for Understanding (initial t=2.49, P=.01; 9-month t=3.22, P<.01) and Reasoning (initial t=2.18, P=.03; 9-month t=4.77, P<.01). Declining capacity over 9 months was attributable to a further reduction in Reasoning (group x time F=9.44, P=.003). Discriminant function analysis revealed that initial scores on naming, delayed Logical Memory, and Trails B were associated with impaired capacity at 9 months.

CONCLUSIONS

Some patients with mild-to-moderate dementia develop a clinically relevant impairment of consent capacity within a year. Consent capacity in adults with mild-to-moderate dementia should be reassessed periodically to ensure that it is adequate for each specific informed consent situation. Interventions that maximize Understanding and Reasoning by supporting naming, memory, and flexibility may help to optimize capacity in this patient group.

摘要

背景

患有痴呆症的老年人做出医疗治疗决策的能力可能会下降。

目的

研究痴呆症老年人在9个月内治疗决策或同意能力的发生率及神经心理学预测因素。

设计

采用纵向重复测量设计,对有或无痴呆症的受试者在初始阶段和9个月后评估同意能力。

参与者

53名患有痴呆症的老年人和53名年龄相仿的无痴呆症成年人。

测量方法

使用标准化的麦克阿瑟能力评估工具-治疗,评估4项能力的法律标准(理解、领会、推理和表达选择)以及一套神经心理测试。

结果

在痴呆症组中,9.4%的人初始能力受损,26.4%的人在9个月时能力受损。痴呆症组的平均得分在初始阶段和9个月时相对于对照组在理解方面受损(初始t=2.49,P=.01;9个月时t=3.22,P<.01)和推理方面受损(初始t=2.18,P=.03;9个月时t=4.77,P<.01)。9个月内能力下降归因于推理能力的进一步下降(组×时间F=9.44,P=.003)。判别函数分析显示,命名、延迟逻辑记忆和连线测验B的初始得分与9个月时的能力受损有关。

结论

一些轻度至中度痴呆症患者在一年内会出现具有临床意义的同意能力损害。对于轻度至中度痴呆症成年人的同意能力应定期重新评估,以确保其适用于每种具体的知情同意情况。通过支持命名、记忆和灵活性来最大化理解和推理的干预措施可能有助于优化该患者群体的能力。

相似文献

8
Medical decision-making capacity and cataract surgery.医疗决策能力与白内障手术
Optom Vis Sci. 2012 Oct;89(10):e23-6. doi: 10.1097/OPX.0b013e31826a3d85.

引用本文的文献

6
Anxiety Impacts Consent Capacity to Treatment in Alzheimer's Disease.焦虑影响阿尔茨海默病患者的治疗同意能力。
Front Psychol. 2021 Jun 14;12:685430. doi: 10.3389/fpsyg.2021.685430. eCollection 2021.

本文引用的文献

5
Enhancing informed consent for research and treatment.加强研究和治疗中的知情同意。
Neuropsychopharmacology. 2001 Jun;24(6):595-607. doi: 10.1016/S0893-133X(00)00218-9.
8
Racial variations in end-of-life care.临终关怀中的种族差异。
J Am Geriatr Soc. 2000 Jun;48(6):658-63. doi: 10.1111/j.1532-5415.2000.tb04724.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验